You are here

Coartem

WHO prequalifies Novartis' Coartem for malaria

BioPharma Dive

Mon, 07/20/15 - 11:04 am

Daily Malaria Drug Matches Twice-a-Day Novartis Pill

Bloomberg

Fri, 04/23/10 - 07:46 am

Novartis is FDA's first priority review voucher recipient for gaining approval of a tropical disease therapy

InVivo

Thu, 04/9/09 - 09:09 am

review vouchers